We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Rapid7
RPD
$882M
| $19.6M | 0.05% |
+432,075
| New | +$24.3M |
2019 Q3
0 quarters
|
|
327
Public Service Enterprise Group
PEG
$35B
| $19.2M | 0.05% |
309,755
+10,566
| +4% | +$631K |
2017 Q3
8 quarters
|
|
328
Bank of New York Mellon
BNY
$96.4B
| $19.2M | 0.05% |
424,339
-10,894
| -3% | -$485K |
2017 Q3
8 quarters
|
|
|
AENZ
329
DELISTED
Aenza S.A.A.
AENZ
| $19.1M | 0.05% |
2,650,660
+29,407
| +1% | +$239K |
2018 Q4
3 quarters
|
|
330
Regency Centers
REG
$13.4B
| $19M | 0.05% |
273,837
-50,414
| -16% | -$3.36M |
2017 Q3
8 quarters
|
|
331
Humana
HUM
$51.9B
| $18.9M | 0.05% |
74,056
-17,726
| -19% | -$4.97M |
2017 Q3
8 quarters
|
|
|
HHR
332
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $18.8M | 0.05% |
972,311
+355,266
| +58% | +$6.57M |
2019 Q2
1 quarter
|
|
333
iShares China Large-Cap ETF
FXI
$3.94B
| $18.6M | 0.05% |
+468,000
| New | +$19M |
2019 Q3
0 quarters
|
|
334
The Kraft Heinz Company
KHC
$27.6B
| $18.5M | 0.05% |
663,622
-63,508
| -9% | -$1.83M |
2017 Q3
8 quarters
|
|
335
Cencora
COR
$65.2B
| $18.5M | 0.05% |
224,238
-6,628
| -3% | -$570K |
2017 Q3
8 quarters
|
|
336
Nucor
NUE
$57.8B
| $18.4M | 0.05% |
360,614
-47,722
| -12% | -$2.49M |
2017 Q3
8 quarters
|
|
337
Leidos
LDOS
$15.6B
| $18.3M | 0.05% |
213,663
-5,968
| -3% | -$500K |
2018 Q1
6 quarters
|
|
338
Cardinal Health
CAH
$58.7B
| $18.3M | 0.05% |
388,255
-216,024
| -36% | -$9.86M |
2017 Q3
8 quarters
|
|
339
Douglas Emmett
DEI
$1.61B
| $18.2M | 0.05% |
424,112
+205,259
| +94% | +$8.49M |
2017 Q3
8 quarters
|
|
340
Bandwidth Inc
BAND
$1.6B
| $18.2M | 0.05% |
278,798
+16,457
| +6% | +$1.28M |
2019 Q2
1 quarter
|
|
341
Global Payments
GPN
$22.3B
| $18.1M | 0.05% |
113,853
+51,533
| +83% | +$8.41M |
2017 Q3
8 quarters
|
|
342
Coca-Cola Europacific Partners
CCEP
$48.2B
| $18.1M | 0.05% |
325,668
-44,222
| -12% | -$2.47M |
2017 Q4
7 quarters
|
|
343
HCA Healthcare
HCA
$101B
| $18M | 0.04% |
149,281
-21,964
| -13% | -$2.84M |
2017 Q3
8 quarters
|
|
344
Tyson Foods
TSN
$19B
| $17.9M | 0.04% |
208,298
-211,464
| -50% | -$18M |
2017 Q3
8 quarters
|
|
345
Edwards Lifesciences
EW
$50.8B
| $17.9M | 0.04% |
244,113
-2,322
| -0.9% | -$163K |
2017 Q3
8 quarters
|
|
346
Analog Devices
ADI
$196B
| $17.8M | 0.04% |
159,245
-1,878
| -1% | -$213K |
2017 Q3
8 quarters
|
|
347
Sabra Healthcare REIT
SBRA
$4.93B
| $17.6M | 0.04% |
768,579
+277,767
| +57% | +$5.92M |
2018 Q2
5 quarters
|
|
348
Illumina
ILMN
$40.5B
| $17.5M | 0.04% |
59,054
-11,079
| -16% | -$3.27M |
2017 Q3
8 quarters
|
|
349
Ross Stores
ROST
$75B
| $17.2M | 0.04% |
156,780
-72,197
| -32% | -$7.62M |
2017 Q3
8 quarters
|
|
350
DELISTED
ENVESTNET, INC.
ENV
| $17.1M | 0.04% |
302,000
+18,780
| +7% | +$1.19M |
2019 Q2
1 quarter
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.